Гематология / лейкозы / лимфомы

Expanding CAR T and Bispecific Antibody Research in HIV-Associated Lymphoma

Global Platform Trial Aims to Transform Treatment of Children With Relapsed B-Cell Lymphoma

Global Platform Trial Aims to Transform Treatment of Children With Relapsed B-Cell Lymphoma Bioengineer.org

Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference

Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference Oncodaily

Making Outpatient Cellular Therapy Dosing the Default in Multiple Myeloma

Blood Cancer Research Award Advances Lymphoma Clinical Trials

Blood Cancer Research Award Advances Lymphoma Clinical Trials University of Miami

IMS 2026: Key Updates Across The Multiple Myeloma Paradigm

Novel CAR-T Therapy for Hard-to-Treat Multiple Myeloma Shows Promising Safety and Durable Responses | Newswise

Novel CAR-T Therapy for Hard-to-Treat Multiple Myeloma Shows Promising Safety and Durable Responses | Newswise newswise.com

Ciltacabtagene Autoleucel Manufacturing, Debulking, and Bridging in Multiple Myeloma

Referral Barriers to Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma

EXCALIBER-RRMM: Iberdomide in Relapsed/Refractory Multiple Myeloma

Introduction to CELMoDs in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — The Comorbid, Higher-Risk Patient, and Program Conclusions

Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — The Fit, Immunotherapy-Eligible Patient in Second Line

Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — Rapidly Progressive Earlier-Relapse Disease

Relapsed/Refractory Multiple Myeloma: Debate — Contextualizing Safety and Sequencing BCMA-Directed Therapies